Apoptosis(凋亡)
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
Products for Apoptosis
- Caspase(85)
- 14.3.3 Proteins(1)
- Apoptosis Inducers(43)
- Bax(7)
- Bcl-2 Family(106)
- Bcl-xL(8)
- c-RET(9)
- IAP(26)
- KEAP1-Nrf2(64)
- MDM2(12)
- p53(112)
- PC-PLC(4)
- PKD(8)
- RasGAP (Ras- P21)(1)
- Survivin(6)
- Thymidylate Synthase(10)
- TNF-α(128)
- Other Apoptosis(885)
- APC(5)
- PD-1/PD-L1 interaction(60)
- ASK1(3)
- PAR4(2)
- RIP kinase(50)
- FKBP(19)
- Pyroptosis(30)
- Cat.No. 产品名称 Information
- GC31878 PD1-IN-2 PD1-IN-2 是一种 PD1 信号通路抑制剂,可作为免疫调节剂。
-
GC31806
Bz 423 (BZ48)
BZ48
Bz 423 (BZ48) 是一种促凋亡的 1,4-苯二氮卓类药物,在狼疮小鼠模型中具有治疗特性,显示出对自身反应性淋巴细胞的选择性,并激活 Bax 和 Bak。 -
GC31783
Methyl 3,4-dihydroxybenzoate (Protocatechuic acid methyl ester)
3,4-二羟基苯甲酸甲酯,Protocatechuic acid methyl ester; Methyl protocatechuate
Methyl protocatechuate (Methyl 3,4-dihydroxybenzoate, 3,4-Dihydroxybenzoic acid methyl ester, Protocatechuic Acid Methyl Ester) is also known as Protocatechuic Acid Methyl Ester. Protocatechuic Acid, a dihydroxybenzoic acid, is a major metabolite of antioxidant polyphenols found in green tea with antioxidant and anti-inflammatory effects. -
GC31753
BMS-1166 (PD-1/PD-L1-IN1)
A PD-1/PD-L1 interaction inhibitor
-
GC31739
Hispidol ((Z)-Hispidol)
(Z)-Hispidol
Hispidol ((Z)-Hispidol) ((Z)-Hispidol ((Z)-Hispidol)) 是炎症性肠病的潜在治疗剂;抑制 TNF-α;诱导单核细胞与结肠上皮细胞的粘附,IC50 为 0.50 μM. -
GC31719
Avelumab (Anti-Human PD-L1, Human Antibody)
阿维鲁单抗; Anti-Human PD-L1, Human Antibody; MSB 0010718C; MSB0010718C
Avelumab (anti-PD-L1) (Bavencio, MSB0010718C) is a fully human IgG1 monoclonal antibody that targets the protein programmed death-ligand 1 (PD-L1). Avelumab exhibits potential antibody-dependent cell-mediated cytotoxicity and is used for the treatment of several kinds of carcinoma. MW=143.8 kDa. -
GC31717
Ginkgetin
银杏双黄酮
A biflavonoid with diverse biological activities -
GC31699
Scopoletin (Gelseminic acid)
东莨菪内酯; Gelseminic acid; Chrysatropic acid
A natural coumarin
-
GC31692
Homoplantaginin
高车前苷
A flavonoid glycoside with antioxidant and anti-inflammatory activities -
GC31691
(+)-DHMEQ
(1R,2R,6R)-Dehydroxymethylepoxyquinomicin; (1R,2R,6R)-DHMEQ
(+)-DHMEQ 是抗氧化转录因子 Nrf2 的激活剂。 - GC31652 RIPA-56 A RIPK1 inhibitor
-
GC31648
4-Octyl Itaconate
4-辛基衣康酸
4-Octyl Itaconate (4-OI) 是一种可渗透细胞的衣康酸酯衍生物。 -
GC31631
Stachyose tetrahydrate
水苏糖四水合物
Stachyose is a natural sugar found in many foods like beans and vegetables.
-
GC31596
Osajin (CID 95168)
CID 95168; NSC 21565
Osajin (CID 95168) 是存在于 Maclura pomifera 果实中的主要生物活性异黄酮,具有抗肿瘤、抗氧化和抗炎活性。 -
GC31511
Sinapinic acid (Sinapic acid)
芥子酸; Sinapic acid
A phenylpropanoid hydroxycinnamic acid with diverse biological activities -
GC31390
EP1013 (F1013)
F1013
EP1013 (F1013) (F1013) 是一种广谱 caspase 选择性抑制剂,用于 1 型糖尿病的研究。 - GC31321 KI696 KI696是一种干扰Keap1/NRF2相互作用的高亲和力探针。
-
GC31186
Citicoline sodium salt
胞磷胆碱钠; Cytidine diphosphate-choline sodium; CDP-Choline sodium; Cytidine 5'-diphosphocholine sodium
An intermediate in the synthesis of phosphatidylcholine
-
GC30910
Eucalyptol (1,8-Cineole)
NSC 6171
Eucalyptol是5-HT3受体,钾通道,TNF-α和IL-1β的抑制剂。 -
GC30896
4-Hydroxybenzyl alcohol
对羟基苯甲醇
A phenol with diverse biological activities -
GC30788
L-Glutamic acid monosodium salt (Monosodium glutamate)
谷氨酸单钠盐
L-Glutamic acid monosodium salt is the sodium salt of glutamic acid, found naturally in tomatoes, cheese and other foods. L-Glutamic acid monosodium salt acts as an excitatory transmitter and an agonist at all subtypes of glutamate receptors (metabotropic, kainate, NMDA, and AMPA). (S)-Glutamic acid shows a direct activating effect on the release of DA from dopaminergic terminals. -
GC30266
L-SelenoMethionine
L-硒代蛋氨酸
A naturally occurring amino acid with antioxidant properties -
GC30240
Calcium dobesilate
羟苯磺酸钙
Calcium dobesilate (calcium dihydroxy-2,5-benzenesulfonate) is a small molecule that has been widely used for treating diabetic retinopathy and chronic venous insufficiency. -
GC30205
S-Allyl-L-cysteine
S-烯丙基-L-半胱氨酸; S- 烯丙基别半胱氨酸
A water soluble organosulfur compound derived from garlic
-
GC30110
Oleic acid (9-cis-Octadecenoic acid)
油酸; 9-cis-Octadecenoic acid; 9Z-Octadecenoic acid
油酸(9-顺式-十八碳烯酸)是一种单不饱和的Omega-9脂肪酸,存在于植物和动物中。 -
GC30085
Neobavaisoflavone
新补骨脂异黄酮
A natural isoflavone -
GC11087
Myristoleic Acid
肉豆蔻酸; 肉豆蔻油酸
A bioactive fatty acid -
GC19457
Trolox
奎诺二甲基丙烯酸酯
Vitamin E derivative with antioxidant properties
-
GC19452
AMG-176
AMG-176
AMG-176 (Tapotoclax) 是一种有效的、选择性的、具有口服活性的 MCL-1 抑制剂,Ki 为 0.13 nM。 - GC19436 CID-5721353 A Bcl-6 inhibitor
- GC19411 IITZ-01 IITZ-01 是一种有效的溶酶体自噬抑制剂,具有单剂抗肿瘤活性,对 PI3Kγ 的 IC50 为 2.62 μM。
-
GC19398
PIM447
LGH447
PIM447 (LGH447) 是一种有效的、口服的、选择性的泛 PIM 激酶抑制剂,对 PIM1、PIM2 和 PIM3 的 Ki 值分别为 6、18 和 9 pM。 PIM447 具有双重抗骨髓瘤和骨保护作用。 PIM447 诱导细胞凋亡。 -
GC19348
TAS-102
TAS-102
An orally bioavailable combination of a nucleoside analog and TPase inhibitor -
GC19346
Talampanel
(8R)-7-乙酰基-5-(4-氨基苯基)-8,9-二氢-8-甲基-7H-1,3-二氧杂环戊烯并[4,5-H][2,3]苯并二氮杂卓,GYKI-53773; LY-300164
An allosteric AMPA receptor antagonist - GC19312 RO8994 An inhibitor of MDM2-p53 interaction
-
GC19306
RAD51 Inhibitor B02
B02
A RAD51 inhibitor - GC19293 PFK-158 PFK-158 是一种有效的选择性 PFKFB3 抑制剂,通过减少癌细胞中葡萄糖的摄取、ATP 的产生、乳酸的释放以及诱导细胞凋亡和自噬,显示出广泛的抗肿瘤活性.PFK-158 在 EC 细胞中以剂量和时间依赖性方式抑制细胞活力。
-
GC19290
PF-3084014
PF-3084014; PF-03084014
An inhibitor of γ-secretase -
GC19268
NVP-HDM201
NVP-HDM201; HDM201
NVP-HDM201 (NVP-HDM201) 是一种有效的、口服生物利用度高且高度特异性的 p53-MDM2 相互作用抑制剂。 -
GC19263
NKP-1339
IT-139; KP-1339
A ruthenium complex with anticancer activity - GC19257 MX69 An inhibitor of the MDM2 protein and XIAP RNA interaction
- GC19254 ML385 ML385是一种特定的核因子红细胞2相关因子2(NRF2)抑制剂。
-
GC19248
Mivebresib
米维布塞; ABBV-075
A BRD2, BRD4, and BRDT inhibitor -
GC19225
PD-1-IN-1 (CA-170)
CA-170
PD-1-IN-1 (CA-170) 是一种具有口服活性的免疫检查点调节蛋白VISTA和PD-L1双重抑制剂。 - GC19215 KRIBB11 An Hsf1 inhibitor
- GC19200 INCB-057643 A BET family protein inhibitor
-
GC19199
Importazole
IPZ
A selective inhibitor of importin-β-mediated nuclear import - GC19198 iCRT3 iCRT3 是 Wnt 和 β-连环蛋白反应性转录的抑制剂。
-
GC19197
IB-MECA
IB-MECA; CF-101
An adenosine A3 receptor agonist -
GC19195
Iberdomide
CC-220
A cereblon modulator